The estimated Net Worth of Erin S. Enright is at least $65.5 mil dollars as of 4 January 2022. Ms. Enright owns over 80,146 units of Dynatronics stock worth over $16,896 and over the last 11 years she sold DYNT stock worth over $0. In addition, she makes $48,600 as Independent Chairman of the Board at Dynatronics.
Sign up
Ms. Enright DYNT stock SEC Form 4 insiders trading
Erin has made over 13 trades of the Dynatronics stock since 2017, according to the Form 4 filled with the SEC. Most recently she bought 80,146 units of DYNT stock worth $12,823 on 4 January 2022.
The largest trade she's ever made was buying 398,010 units of Dynatronics stock on 30 November 2017 worth over $995,025. On average, Erin trades about 29,593 units every 35 days since 2013. As of 4 January 2022 she still owns at least 105,601 units of Dynatronics stock.
You can see the complete history of Ms. Enright stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Erin Enright biography
Erin S. Enright J.D. serves as Independent Chairman of the Board of the Company. She currently serves as a Managing Member of Prettybrook Partners LLC, a family office dedicated to investing in healthcare companies. Prettybrook has approximately 20 active investments in a variety of companies, typically as a co-investor with institutional private equity. She serves as the Chairman of the Board, Chair of the Nominating and Governance Committee and member of the Audit Committee and Compensation Committee of Dynatronics Corporation (NASDAQ: DYNT), and as a member of the Board of Directors and Audit Committee and Investment Committee of Medical Facilities Corporation (TSX: DR) and a member of the Board and Chair of the Audit Committee of Keystone Dental, Inc., a private company controlled by the private equity firm Accelmed. Previously, she served on the Board of Directors and the Audit Committee of Biolase, Inc. (NASDAQ: BIOL) during 2013, was a member of the Board of Directors of Tigerlabs, a Princeton-based business accelerator, from 2012 to 2018, and from 2010 to 2015 served on the Board of Directors of Ceelite Technologies, LLC. She was the President of Lee Medical, a medical device manufacturer based in Plainsboro, New Jersey, from 2004-13. She was Chief Financial Officer of InfuSystem, Inc. (NASDAQ:INFU) from 2005 to 2007. From 1993 to 2003, Ms. Enright was with Citigroup, most recently as a Managing Director in its Equity Capital Markets group. While at Citigroup, Ms. Enright was Chairperson of the firm's Institutional Investors' Committee, responsible for screening and approving the firm's participation in equity underwritings and a member of the Citigroup Global Equity Commitment Committee, responsible for reviewing and approving the firm's underwritings. From 1989 until 1993, Ms. Enright was an attorney with Wachtell, Lipton, Rosen & Katz in the firm's New York office. Ms. Enright received her A.B. degree from the Woodrow Wilson School of Public and International Affairs at Princeton University.
What is the salary of Erin Enright?
As the Independent Chairman of the Board of Dynatronics, the total compensation of Erin Enright at Dynatronics is $48,600. There are 4 executives at Dynatronics getting paid more, with Brian D. Baker having the highest compensation of $5,159,387.
How old is Erin Enright?
Erin Enright is 58, she's been the Independent Chairman of the Board of Dynatronics since 2018. There are 2 older and 11 younger executives at Dynatronics. The oldest executive at Dynatronics Corp. is R. Scott Ward, 63, who is the Independent Director.
What's Erin Enright's mailing address?
Erin's mailing address filed with the SEC is 512 WEST MLK JR. BLVD #320, , AUSTIN, TX, 78701.
Insiders trading at Dynatronics
Over the last 21 years, insiders at Dynatronics have traded over $277,594 worth of Dynatronics stock and bought 3,744,819 units worth $3,168,592 . The most active insiders traders include Stuart Essig, Erin S. Enright y Ventures 1 Lp Provco. On average, Dynatronics executives and independent directors trade stock every 54 days with the average trade being worth of $5,399. The most recent stock trade was executed by R Scott Ward on 4 January 2022, trading 5,000 units of DYNT stock currently worth $800.
What does Dynatronics do?
dynatronics manufactures, markets, and distributes advanced-technology medical devices, treatment tables, and rehabilitation - acute-care - sport medicine - chiropractic - massage equipment as well as over 8,000 products and supplies. in addition, dynatronics has the most experienced and knowledgeable sales force in the industry. with more than 60 sales representatives and 150 active distributors located throughout the country, we are able to provide immediate service. dynatronics has built a solid reputation over the past 31 years for competitive pricing, excellent customer service, and unmatched clinical support. our field support team handles everything from equipment set-up to in-service training.
What does Dynatronics's logo look like?
Complete history of Ms. Enright stock trades at Amarin Corp, Biolase Inc y Dynatronics
Dynatronics executives and stock owners
Dynatronics executives and other stock owners filed with the SEC include:
-
Brian D. Baker,
Director & Consultant -
John A. Krier,
CEO, Pres & Director -
Norman Roegner III,
Chief Financial Officer -
Brian Baker,
Director -
Erin Enright,
Independent Chairman of the Board -
Norman Roegner,
Chief Financial Officer -
John Krier,
Chief Executive Officer, Director -
Ed Staten,
Senior Director of Sales Operations -
Jennifer Keeler,
General Counsel -
R. Scott Ward,
Independent Director -
Brian Larkin,
Independent Director -
Scott Klosterman,
Independent Director -
David Holtz,
Independent Director -
Skyler Black,
Principal Accounting Officer -
James Ogilvie,
Vice President - Corporate Development -
Mark A. Crockett,
Consultant -
Sarah Rome-Mealman,
VP of Marketing -
Jason C. Anderson,
Chief Information Officer -
Robert J Cardon,
Secretary/Treasurer -
David Alma Wirthlin,
Chief Financial Officer -
Ventures 1 Lp Provco,
10% owner -
Larry K Beardall,
Exec. Vice President -
Stuart Essig,
10% owner -
Jako Christopher Richard Von,
Chief Executive Officer -
Thomas J Gephart,
Vice President of Sales -
Nancy Cronin,
-
Kelvyn H Jr Cullimore,
Chief Executive Officer -
Howard L Edwards,
Director -
Joseph H Barton,
Director -
Val John Christensen,
Director -
Terry M Atkinson,
Chief Financial Officer -
Kelvyn H Cullimore,
Chairman of the Board -
E Keith Hansen,
Director -
James E Woods,
-
Ronald J Hatch,
VP Prod/R&D -
Corp Dynatronics,
-
Andrew Hulett,
Director